Baseline differences between vascular cognitive impairment no dementia reverters and non-reverters

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 79, Issue 11, 2008, Pages 1208-1214

  Williamson, J B ^a,c   Nyenhuis, D L ^a   Pedelty, L ^a   Byrd, S ^b   Jhaveri, M ^b   Wang, C ^b   Detoledo Morrell, L ^b   Sripathirathan, K ^b   Gorelick, P ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c Center for Stroke Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL EXAMINATION; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMOGRAPHY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; RATING SCALE; REVERTANT; WHITE MATTER; WORKING MEMORY; ATROPHY; BRAIN; BRAIN CIRCULATION; HOSPITALIZATION; MIDDLE AGED; MULTIINFARCT DEMENTIA; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOMOTOR DISORDER; VASCULARIZATION;

AGED; ATROPHY; BRAIN; CEREBROVASCULAR CIRCULATION; COGNITION DISORDERS; DEMENTIA, VASCULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR DISORDERS; SEVERITY OF ILLNESS INDEX;

EID: 55249109423     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2007.137554     Document Type: Article

References (42)

1. Gorelick PB, Román G, Mangone CA. In: Gorelick PB, Alter MA, eds. Handbook of Neuroepidemiology. New York: Marcel Dekker, 1994:197-214.
2. Hachinski V. Vascular dementia: a radical redefinition. Dementia 1994;5:130-32.
3. Rockwood K, Howard K, MacKnight C, et al. Spectrum of disease in vascular cognitive impairment. Neuroepidemiology 1999;18:248-54.
4. Nyenhuis DL, Gorelick PB, Geenen EJ, et al. The pattern of neuropsychological deficits in Vascular Cognitive Impairment - No Dementia (Vascular CIND). Clin Neuropsychol 2004;18:41-9.
5. Peterson RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-8.
6. Ganguli M, Dodge HH, Changy S, et al. Mild cognitive impairment, amnestic type. An epidemiologic study. Neurology 2004;63:115-21.
7. Stoub TR, Bulgakova M, Leurgans S, et al. MRI predictors of risk of incident Alzheimer disease: A longitudinal study. Neurology 2005;64:1520-4.
8. Ravaglia G, Forti P, Maioli F, et al. Conversion of mild cognitive impairment to dementia: predictive role of mild cognitive impairment subtypes and vascular risk factors. Dement Geriatr Cogn Disord 2006;21:51-8.
9. Wang C, Stebbins GT, Nyenhuis DL, et al. Longitudinal changes in white matter following ischemic stroke: A three-year follow-up study. Neurobiol Aging 2006;27:1827-33.
10. Foulkes MA, Wolf PA, Price TR, et al. The stroke data bank: design, methods, and characteristics. Stroke 1988;19:547-54.
11. Brott T, Adams HP, Olinger CP, et al. Measurement of acute cerebral infarction: a clinical examination scale. Stroke 1989;20:864-70.
12. Gorelick PB, Freels S, Harris Y, et al. Epidemiology of vascular and Alzheimer's dementia among African-Americans in Chicago, IL: baseline frequency and comparison of risk factors. Neurology 1994;44:1391-6.
13. Wechsler D. WMS-III Administration and Scoring Manual. San Antonio, TX: The Psychological Corporation, Harcourt Brace Jovanovich, 1997.
14. Wechsler D. A standardized memory scale for clinical use. J Psychol 1945;19:87-95.
15. Shimamura A, Jurica P. Memory interference effects and aging: Findings from a test of frontal lobe function. Neuropsychology 1994;1:408-12.
16. Grisby J, Kaye K. Behavior Dyscontrol Scale: Manual. Denver, CO, 1996.
17. nd ed. Philadelphia: Lea and Febiger, 1989.
18. Morris JC, Heyman A, Mohrs RC, et al, and the CERAD Investigators. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part 1. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-65.
19. Scherr PA, Albert MS, Funkenstein HH, et al. Correlates of cognitive function in an elderly community population. Am J Epidem 1988;128:1084-1101.
20. Raven JC. Colored Progressive Matrices Sets A, AB, B. Oxford, England: University Press Ltd., 1995.
21. Russell E, Starkey R. Halstead-Russell Neuropsychological Evaluation System (HRNES). Los Angeles: Western Psychological Services, 1993.
22. Smith A. Symbol Digit Modalities Test. Los Angeles: Western Psychological Services, 1991.
23. Buschke H, Grober E. Genuine memory deficits in age-associated memory impairment. Dev Neuropsychol 1986;2:287-307.
24. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Neurology 1993;43:250-60.
25. Ebly EM, Hogan DB, Parhad IM. Cognitive impairment in the nondemented elderly: results from the Canadian Study of Health and Aging. Arch Neurol 1995;52:612-9.
26. Manolio TA, Kronmal RA, Burke GL, et al. Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study. Stroke 1994;25:318-27.
27. Scheltens P, Barkhof F, Leys D, et al. A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 1993;114:7-12.
28. Rasquin SMS, Lodder J, Verhey FRJ. Predictors of reversible mild cognitive impairment after stroke: a 2-year follow-up study. J Neurol Sci 2005;229-230:21-5.
29. Tham W, Auchus AP, Thong M, et al. Progression of cognitive impairment after stroke: one year results from a longitudinal study of Singaporean stroke patients. J Neurol Sci 2002;203-204:49-52.
30. Nys GM, Van Zandvoort MJ, De Kort PL, et al. Domain-specific cognitive recovery after first-ever stroke: a follow-up study of 111 cases. J Int Neuropsychol Soc 2005;11:795-806.
31. Unverzagt FW, Gao S Baiyewu, Ogunniyi AO, et al. Prevalence of cognitive impairment: data from the Indianapolis Study of Health and Aging. Neurology 2001;57:1655-62.
32. Hochstenbach JB, den Otter R, Mulder TW. Cognitive recovery after stroke: a 2-year follow-up. Arch Phys Med Rehabil 2003;84:1499- 504.
33. Desmond DW, Moroney JT, Sano M, et al. Recovery of cognitive function after stroke. Stroke 1996;27:1798-803.
34. Tatemichi TK, Paik M, Bagiella E, et al. Risk of dementia after stroke in a hospitalized cohort: Results of a longitudinal study. Neurology 1994; 44:1885-91.
35. Bornstein NM, Gur AY, Treves TA, et al. Do silent brain infarctions predict the development of dementia after first ischemic stroke? Stroke 1996;25:904-5.
36. Reed BR, Eberling JL, Mungas D, et al. Effects of white matter lesions and lacunes on cortical function. Arch Neurol 2004;61:1545-50.
37. Moser DM, Cohen RA, Paul RH, et al. Executive function and magnetic resonance imaging subcortical hyperintensities in vascular dementia. Neuropsychiatry Neuropsychol Behav Neurol 2001;14:89-92.
38. Gootjes L, Teipel SJ, Zebuhr Y, et al. Regional distribution of white matter hyperintensities in Vascular Dementia, Alzheimer's disease, and healthy aging. Dement Geriatr Cogn Disord 2004;18:180-8.
39. Tullberg M, Fletcher E, DeCarli C, et al. White matter lesions impair frontal lobe function regardless of their location. Neurology 2004;63:246-53.
40. Prins ND, van Dijk EJ, den Heijer T, et al. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain 2005;128:2034-41.
41. Geenen EJ, Nyenhuis DL, Gencheva E, et al. Comparison of VaD frequency using NINDS-AIREN and ADDTC diagnostic criteria. J Int Neuropsychol Soc 2003;9:166.
42. O'Sullivan M, Morris RG, Huckstep B, et al. Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis. J Neurol Neurosurg Psychiatry 2004;75:441-7.